Scott Longval stepped in as Intricon’s first non-founder CEO in 2020, during a time of evolution for the Arden Hills-based manufacturer of micro medical technology. As CEO, his first hire was a chief human resources officer. In 2022, Longval pivoted Intricon from public to private, which “enabled [Intricon] to think differently about how we were going to accelerate growth across the organization.” After adding an advanced R&D lab at its HQ and expanding a manufacturing plant in Indonesia at the end of 2024, Intricon will be starting construction in Costa Rica on a plant building sensor-driven medical devices.

Return to TCB 100 for 2024